Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Three Transfusion Strategies for Central Venous Catheterization in Cirrhotics: A Randomized Clinical Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Chronic liver failure (cirrhosis or chronic graft dysfunction) from any cause and medical indication of central venous line placement~Exclusion Criteria:~* Acute liver failure or~* Use of therapeutic doses of oral or parenteral anticoagulants (unfractionated heparin or low molecular weight heparin or oral anticoagulants) or~* Use of oral or parenteral platelet aggregation inhibitors or~* Patients with von Willebrand syndrome or~* Over-the-guidewire central venous catheter changing~* Patients previously included in this study protocol during the same hospital stay

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Coagulogram-based protocol (Type: ACTIVE_COMPARATOR): Arm based on standard coagulation tests protocol to guide blood transfusion before central venous catheterization. The possible components to be used include fresh frozen plasma, platelets (random or aphaeresis) and or cryoprecipitate.
- Thromboelastometry-based protocol (Type: EXPERIMENTAL): Arm based on rotational thromboelastometry (ROTEM(R)) protocol to guide blood transfusion before central venous catheterization. The possible components to be used include fresh frozen plasma, platelets (random or aphaeresis) and or cryoprecipitate.
- Restrictive strategy (Type: EXPERIMENTAL): Arm based on a restrictive protocol strategy based on INR/PT and platelets count. The possible components to be used include fresh frozen plasma and/or platelets (random or aphaeresis).

Based on this trial design, predict the completion outcome and termination type (if applicable).